logo IST    

istituto nazionale per la ricerca sul cancro

Home Mappa del sito Cerca Informazioni al pubblico Clinica e Ricerca Intranet

Epidemiologia clinica

Pubblicazioni



 punto elenco Presentazione della struttura
 punto elenco Staff
 punto elenco Attrezzature e metodi
 punto elenco Progetti finalizzati
 punto elenco Trials clinici
 punto elenco Pubblicazioni


BOLOGNESI C.-BALIA C.-ROGGIERI P.-CARDINALE F.-BRUZZI P.- SORCINELLI F.-LISTA F.-D'AMELIO R.-RIGHI E.
Micronucleus test for radiation biodosimetry in mass casualty events: evaluation of visual and automated scoring.
Radiat. Meas. 46:169/175, 2011

CALCAGNO C.-PUZONE R.-PEARSON Y.E.-CHENG Y.-GHERSI D.-SELIN L.K.- WELSH R.-CELADA F.
Computer simulations of heterologous immunity: highlights of an interdisciplinary cooperation.
Autoimmunity 44(4):304/314, 2011
PubMed Abstract

CANAVESE G.-DOZIN B.-VECCHIO C.-TOMEI D.-VILLA G.-CARLI F.-DEL MASTRO L.-LEVAGGI A.-ROSSELLO C.-SPINACI S.-BRUZZI P.-CATTURICH A.
Accuracy of sentinel lymph node biopsy after neo adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes.
Eur. J. Surg. Oncol. 37:688/694, 2011
PubMed Abstract

GENNARI A.-STOCKLER M.-PUNTONI M.-SORMANI M.-NANNI O.-AMADORI D.- WILCKEN N.-D'AMICO M.-DECENSI A.-BRUZZI P.
Duration of chemotherapy for metastatic breast cancer: a systematic review and meta analysis of randomized clinical trials.
J. Clin. Oncol. 29(16):2144/2149, 2011
PubMed Abstract

PEARSON Y.E.-CHENG Y.-SELIN L.K.-PUZONE R.-CELADA F.
Systematic simulation of cross reactivity predicts ambiguity in Tk memory: it may save lives of the infected, but limits specificities vital for further responses.
Autoimmunity 44(4):315/327, 2011
PubMed Abstract

SELIN L.K.-WLODARCZYK M.-KRAFT A.-NIE S.-KENNEY L.-PUZONE R.- CELADA F.
Heterologous immunity: immunopathology, autoimmunity and protection during viral infections.
Autoimmunity 44(4):328/347, 2011
PubMed Abstract

SOBRERO A.-BRUZZI P.
Vatalanib in advanced colorectal cancer: two studies with identical results.
J. Clin. Oncol. 29(15):1938/1940, 2011
PubMed Abstract



BECCARO M.-CARACENI A.-COSTANTINI M.-ISDOC Study Group-DI LEO S.- BRUZZI P.-MERLO D.F.-MORASSO G.
End of life care in Italian hospitals: quality of and satisfaction with care from the caregivers' point of view. Results from the Italian Survey of the Dying of Cancer.
J. Pain Symptom Manage. 39(6):1003/1015, 2010
PubMed Abstract

CANAVESE G.-BRUZZI P.-CATTURICH A.-VECCHIO C.-TOMEI D.-CARLI F.- TRUINI M.-ANDREOLI G.B.-PRIANO V.-DOZIN B.
Intraoperative evaluation of the sentinel lymph node for T1/N0 breast cancer patients: always or never? A risk/benefit and cost/benefit analysis.
Eur. J. Surg. Oncol. 36:737/744, 2010
PubMed Abstract

CORREA C.-MCGALE P.-TAYLOR C.-WANG Y.-CLARKE M.-DAVIES C.-PETO R.- BIJKER N.-SOLIN L.-DARBY S.-Early Breast Cancer Trialists' Collaborative Group (EBCTCG)-BOCCARDO F.-RUBAGOTTI A.-BRUZZI P.- DEL MASTRO L.-PRONZATO P.-SERTOLI M.R.-VENTURINI M.
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
J. Natl. Cancer Inst. Monogr. 2010(41):162/177, 2010
PubMed Abstract

GREGORC V.-ZUCALI P.-SANTORO A.-CERESOLI G.-CITTERIO G.-DE PAS T.- ZILEMBO N.-DE VINCENZO F.-SIMONELLI M.-ROSSONI G.-SPREAFICO A.- VIGANO' M.-FONTANA F.-DE BRAUD F.-BAJETTA E.-CALIGARIS CAPPIO F.- BRUZZI P.-LAMBIASE A.-BORDIGNON C.
Phase II study of asparagine/glycine/arginine human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma.
J. Clin. Oncol. 28(15):2604/2611, 2010
PubMed Abstract

LAURENT S.-CARREGA P.-SAVERINO D.-PICCIOLI P.-CAMORIANO M.- MORABITO A.-DOZIN B.-FONTANA V.-SIMONE R.-MORTARA L.-MINGARI M.C.- FERLAZZO G.-PISTILLO M.P.
CTLA/4 is expressed by human monocyte derived dendritic cells and regulates their functions.
Hum. Immunol. 71:934/941, 2010
PubMed Abstract

PUZONE R.-PALEARI L.-MONTEFIORE F.-RUGGIERO L.-PUNTONI M.- MAFFEZZINI M.-BOBBIO B.-MARRONI P.-LIBENER R.-BETTA P.G.
Osteopontin plasma level does not detect prostate cancer in patients referred for diagnostic prostate biopsy.
Int. J. Biol. Markers 25(4):200/206, 2010
PubMed Abstract



BELLINI M.-BOVE A.-SORMANI M.-BATTAGLIA E.-BOCCHINI R.-ALDUINI P.- BASSOTTI G.-BRUZZI P.-PUCCIANI F.-Italian Constipation Study Group
The daily diary and the questionnaire are not equivalent for the evaluation of bowel habits.
Dig. Liver Dis. 42:99/102, 2010 - Epub May 25, 2009
PubMed Abstract

CANAVESE G.-CATTURICH A.-VECCHIO C.-TOMEI D.-GIPPONI M.-VILLA G.- CARLI F.-BRUZZI P.-DOZIN B.
Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial.
Ann. Oncol. 20:1001/1007, 2009
PubMed Abstract

CICERI F.-BONINI C.-STANGHELLINI M.-BONDANZA A.-TRAVERSARI C.- SALOMONI M.-TURCHETTO L.-COLOMBI S.-BERNARDI M.-PECCATORI J.- PESCAROLLO A.-SERVIDA P.-MAGNANI Z.-PERNA S.-VALTOLINA V.-CRIPPA F.-CALLEGARO L.-SPOLDI E.-CROCCHIOLO R.-FLEISCHHAUER K.-PONZONI M.- VAGO L.-ROSSINI S.-SANTORO A.-TODISCO E.-APPERLEY J.-OLAVARRIA E.- SLAVIN S.-WEISSINGER E.-GANSER A.-STADLER M.-YANNAKI E.-FASSAS A.- ANAGNOSTOPOULOS A.-BREGNI M.-STAMPINO C.-BRUZZI P.-BORDIGNON C.
Infusion of suicide gene engineered donor lymphocytes after family haploidentical haemopoietic stem cell transplantation for leukaemia (the TK007 trial): a non randomised phase I/II study.
Lancet Oncol. 10:489/500, 2009
PubMed Abstract

DE BERNARDI B.-GERRARD M.-BONI L.-RUBIE H.-CANETE A.-DI CATALDO A.- CASTEL V.-FORJAZ DE LACERDA A.-LADENSTEIN R.-RUUD E.-BRICHARD B.- COUTURIER J.-ELLERSHAW C.-MUNZER C.-BRUZZI P.-MICHON J.-PEARSON A.
Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification.
J. Clin. Oncol. 27:1034/1040, 2009
PubMed Abstract

GREGORC V.-CITTERIO G.-VITALI G.-SPREAFICO A.-SCIFO P.-BORRI A.- DONADONI G.-ROSSONI G.-CORTI A.-CALIGARIS CAPPIO F.-DEL MASCHIO A.- ESPOSITO A.-DE COBELLI F.-DELL'ACQUA F.-TROYSI A.-BRUZZI P.- LAMBIASE A.-BORDIGNON C.
Defining the optimal biological dose of NGR/hTNF, a selective vascular targeting agent, in advanced solid tumours.
Eur. J. Cancer 46:198/206, 2010 - Epub Nov 7, 2009
PubMed Abstract

MORABITO A.-DOZIN B.-SALVI S.-PASCIUCCO G.-BALBI G.-LAURENT S.- PASTORINO S.-CARLI F.-TRUINI M.-BRUZZI P.-DEL MASTRO L.-PISTILLO M.P.
Analysis and clinical relevance of human leukocyte antigen class I, heavy chain, and beta2/microglobulin downregulation in breast cancer.
Hum. Immunol. 70:492/495, 2009
PubMed Abstract

PAGLIARO L.-BRUZZI P.-BOBBIO M.
Why are Cochrane hepato biliary reviews undervalued by physicians as an aid for clinical decision making?
Dig. Liver Dis. 42:1/5, 2010 - Epub Aug 8, 2009
PubMed Abstract

PALEARI L.-ROTOLO N.-IMPERATORI A.-PUZONE R.-SESSA F.-FRANZI F.- MEACCI E.-CAMPLESE P.-CESARIO A.-PAGANUZZI M.
Osteopontin is not a specific marker in malignant pleural mesothelioma.
Int. J. Biol. Markers 24:112/117, 2009
PubMed Abstract

PICCIOLI P.-BALBI G.-SERRA M.-MORABITO A.-LAMPARELLI T.-GOBBI M.- LAURENT S.-DOZIN B.-BRUZZI P.-FERRARIS A.M.-BACIGALUPO An.-NOTARO R.-PISTILLO M.P.
CTLA/4 +49A>G polymorphism of recipients of HLA matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence.
Ann. Hematol. 89:613/618, 2010 - Epub Dec 18, 2009
PubMed Abstract

RATTO G.B.-COSTA R.-MAINERI P.-ALLOISIO A.-BRUZZI P.-DOZIN B.
Is there a subset of patients with preoperatively diagnosed N2 non small cell lung cancer who might benefit from surgical resection?
J. Thorac. Cardiovasc. Surg. 138:849/858, 2009
PubMed Abstract

REGGE D.-LAUDI C.-GALATOLA G.-DELLA MONICA P.-BONELLI L.-ANGELELLI G.-ASNAGHI R.-BARBARO B.-BARTOLOZZI C.-BIELEN D.-BONI L.-BORGHI C.- BRUZZI P.-CASSINIS M.-GALIA M.-GALLO T.-GRASSO A.-HASSAN C.-LAGHI A.-MARTINA M.-NERI E.-SENORE C.-SIMONETTI G.-VENTURINI S.-GANDINI G.
Diagnostic accuracy of computed tomographic colonography for the detection of advanced neoplasia in individuals at increased risk of colorectal cancer.
JAMA 301:2453/2461, 2009
PubMed Abstract

SOBRERO A.-BRUZZI P.
Incremental advance or seismic shift? The need to raise the bar of efficacy for drug approval.
J. Clin. Oncol. 27:5868/5873, 2009
PubMed Abstract

SOLARI N.-GIPPONI M.-STELLA M.-QUEIROLO P.-DI SOMMA C.-VILLA G.- PICCARDO A.-GUALCO M.-CARDINALE F.-CAFIERO F.
Predictive role of preoperative lymphoscintigraphy on the status of the sentinel lymph node in clinically node negative patients with cutaneous melanoma.
Melanoma Res. 19:243/251, 2009
PubMed Abstract

SORMANI M.-BONZANO L.-ROCCATAGLIATA L.-CUTTER G.-MANCARDI G.- BRUZZI P.
Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta analytic approach.
Ann. Neurol. 65:268/275, 2009
PubMed Abstract

SPIRITO P.-AUTORE C.-RAPEZZI C.-BERNABO' P.-BADAGLIACCA R.-MARON M.-BONGIOANNI S.-COCCOLO F.-ESTES N.-BARILLA' C.-BIAGINI E.-QUARTA G.-CONTE M.-BRUZZI P.-MARON B.
Syncope and risk of sudden death in hypertrophic cardiomyopathy.
Circulation 119:1703/1710, 2009
PubMed Abstract

TINARI N.-LATTANZIO R.-QUERZOLI P.-NATOLI C.-GRASSADONIA A.- ALBERTI S.-HUBALEK M.-REIMER D.-NENCI I.-BRUZZI P.-PIANTELLI M.- IACOBELLI S.-Consorzio Interuniversitario Nazionale Bio Oncologia (CINBO)
High expression of 90K (Mac/2 BP) is associated with poor survival in node negative breast cancer patients not receiving adjuvant systemic therapies.
Int. J. Cancer 124:333/338, 2009
PubMed Abstract



BERRUTI A.-BRIZZI M.-GENERALI D.-ARDINE M.-DOGLIOTTI L.-BRUZZI P.- BOTTINI A.
Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questions.
Oncologist 13:1137/1148, 2008
PubMed Abstract

CATANIA G.-POIRE' I.-DOZIN B.-BERNARDI M.-BONI L.
Validating a measure to delineate the clinical trials nursing role in Italy.
Cancer Nurs. 31:E11/E15, 2008
PubMed Abstract

CHENG Y.-GHERSI D.-CALCAGNO C.-SELIN L.-PUZONE R.-CELADA F.
A discrete computer model of the immune system reveals competitive interactions between the humoral and cellular branch and between cross reacting memory and naive responses.
Vaccine 27:833/845, 2009 - Epub Dec 18, 2008
PubMed Abstract

DE BERNARDI B.-GAMBINI C.-HAUPT R.-GRANATA C.-RIZZO A.-CONTE M.-TONINI G.P.-BIANCHI M.-GIULIANO M.-LUKSCH R.-PRETE A.-VISCARDI E.-GARAVENTA A.-SEMENTA A.-BRUZZI P.-ANGELINI P.
Retrospective study of childhood ganglioneuroma.
J. Clin. Oncol. 26:1710/1716, 2008
PubMed Abstract

DE BERNARDI B.-MOSSERI V.-RUBIE H.-CASTEL V.-FOOT A.-LADENSTEIN R.- LAUREYS G.-BECK M.-DE LACERDA A.-PEARSON A.-DE KRAKER J.-AMBROS P.- DE RYCKE Y.-CONTE M.-BRUZZI P.-MICHON J.
Treatment of localised resectable neuroblastoma. Results of the LNESGI study by the SIOP Europe Neuroblastoma Group.
Br. J. Cancer 99:1027/1033, 2008
PubMed Abstract

GENNARI A.-DE TURSI M.-CARELLA C.-RICEVUTO E.-ORLANDINI C.- FRASSOLDATI A.-CONTE P.-BRUZZI P.-IACOBELLI S.
Epirubicin plus low dose trastuzumab in HER2 positive metastatic breast cancer.
Breast Cancer Res. Treat. 115:131/136, 2009 - Epub Sep 13, 2008
PubMed Abstract

GENNARI A.-PRONZATO P.
New understanding of the role of anthracyclines in early stage breast cancer: patient selection considerations.
Clin. Breast Cancer 8(Suppl 4):S179/S183, 2008
PubMed Abstract

GUARNERI V.-FRASSOLDATI A.-BRUZZI P.-D'AMICO R.-BELFIGLIO M.- MOLINO A.-BERTETTO O.-CASCINU S.-COGNETTI F.-DI LEO A.-PRONZATO P.- CRINO' L.-AGOSTARA B.-CONTE P.
Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER/2 positive breast cancer (Short/HER trial; NCT00629278).
Clin. Breast Cancer 8:453/456, 2008
PubMed Abstract

MERLO D.F.-BECCARO M.-COSTANTINI M.-Italian Survey Dying Cancer Study Group-BRUZZI P.-MORASSO G.-DI LEO S.
An unconventional cancer treatment lacking clinical efficacy remains available to italian cancer patients.
Tumori 94:830/832, 2008
PubMed Abstract

SORMANI M.P.-TINTORE' M.-ROVARIS M.-ROVIRA A.-VIDAL X.-BRUZZI P.- FILIPPI M.-MONTALBAN X.
Will Rogers phenomenon in multiple sclerosis.
Ann. Neurol. 64:428/433, 2008
PubMed Abstract



BECCARO M.-COSTANTINI M.-MERLO D.F.-ISDOC Study Group-BRUZZI P.-MORASSO G.-DI LEO S.
Inequity in the provision of and access to palliative care for cancer patients. Results from the Italian survey of the dying of cancer (ISDOC).
BMC Public Health 7:66;1/66;13, 2007
PubMed Abstract

BRUZZI P.
Non drug industry funded research.
BMJ 336:1/2, 2008 - Epub Dec 6, 2007

CAPPELLANO P.-VISCOLI C.-BRUZZI P.-VAN LINT M.-PEREIRA C.-BACIGALUPO An.
Epidemiology and risk factors for bloodstream infections after allogeneic hematopoietic stem cell transplantation.
New Microbiol. 30:89/99, 2007
PubMed Abstract

CHINI F.-GIORGI P.-MARINACCI C.-BAIOCCHI D.-DE GIACOMI G.-BORGIA P.-GRIMALDI Ma.-ISDOC Working Group-COSTANTINI M.-BECCARO M.- BRUZZI P.-MERLO F.-MORASSO G.-DI LEO S.
Indicatori di stato socio economico e profili familiari: problemi metodologici nello studio dell'impatto sulle famiglie della fase terminale della malattia oncologica.
Epidemiol. Prev. 31:46/55, 2007

CLAVAREZZA M.-DEL MASTRO L.-PRONZATO P.-BRUZZI P.-VENTURINI M.
Re: acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony stimulating factors during breast cancer adjuvant chemotherapy. Letter.
J. Natl. Cancer Inst. 99:1050/1051, 2007

DEL MASTRO L.-DOZIN B.-AITINI E.-CATZEDDU T.-BALDINI E.-CONTU A.-DURANDO A.-DANESE S.-CAVAZZINI G.-CANAVESE G.-BRUZZI P.-PRONZATO P.-VENTURINI M.
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord Ovest Mammella Intergruppo (GONO/MIG) Group.
Ann. Oncol. 19:299/307, 2008 - Epub Oct 17, 2007
PubMed Abstract

GENNARI A.-SORMANI M.-PRONZATO P.-PUNTONI M.-COLOZZA M.-PFEFFER U.-BRUZZI P.
HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials.
J. Natl. Cancer Inst. 100:14/20, 2008 - Epub Dec 25, 2007
PubMed Abstract

GIORGI ROSSI P.-BECCARO M.-MICCINESI G.-BORGIA P.-COSTANTINI M.-CHINI F.-BAIOCCHI D.-DE GIACOMI G.-GRIMALDI M.-MONTELLA M.-ISDOC Working Group-BRUZZI P.-MERLO F.-MORASSO G.-DI LEO S.
Dying of cancer in Italy: impact on family and caregiver. The Italian Survey of Dying of Cancer.
J. Epidemiol. Community Health 61:547/554, 2007
PubMed Abstract

LAURENT S.-PALMISANO G.-MARTELLI A.-KATO T.-TAZZARI P.-PIERRI I.-CLAVIO M.-DOZIN B.-BALBI G.-MEGNA M.-MORABITO A.-LAMPARELLI T.- BACIGALUPO An.-GOBBI M.-PISTILLO M.P.
CTLA/4 expressed by chemoresistant, as well as untreated, myeloid leukaemia cells can be targeted with ligands to induce apoptosis.
Br. J. Haematol. 136:597/608, 2007
PubMed Abstract

MARON B.-SPIRITO P.-SHEN W.-HAAS T.-FORMISANO F.-LINK M.-EPSTEIN A.-ALMQUIST A.-DAUBERT J.-LAWRENZ T.-BORIANI G.-ESTES N.-FAVALE S.- PICCININNO M.-WINTERS S.-SANTINI M.-BETOCCHI S.-ARRIBAS F.-SHERRID M.-BUJA G.-SEMSARIAN C.-BRUZZI P.
Implantable cardioverter defribillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
JAMA 298:405/412, 2007
PubMed Abstract

NOVELLO S.-BRUZZI P.-BARONE C.-BUOSI R.-MASOTTI A.-MICHETTI G.-FIORETTI M.-BARBERA S.-SPATAFORA M.-GARETTO L.-MAZZANTI P.- DONGIOVANNI V.-SELVAGGI G.-CRINO' L.-SCAGLIOTTI G.
Phase III study in stage IV non small cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone.
Ann. Oncol. 18:903/908, 2007
PubMed Abstract

OSTACOLI L.-COSTANTINI M.-BECCARO M.-DELLAI M.-GORZEGNO G.-PICCI R.-SGUAZZOTTI E.-BERRUTI A.-TORTA R.-FURLAN P.
Development and validation of a patient physician relationship index in the advanced cancer setting.
Tumori 93:485/490, 2007
PubMed Abstract

PUNTONI M.-ZANARDI S.-BRANCHI D.-BRUNO S.-CUROTTO A.-VARALDO M.-BRUZZI P.-DECENSI A.
Prognostic effect of DNA aneuploidy from bladder washings in superficial bladder cancer.
Cancer Epidemiol. Biomarkers Prev. 16:979/983, 2007
PubMed Abstract

TERZOLO M.-ANGELI A.-FASSNACHT M.-DAFFARA F.-TAUCHMANOVA L.-CONTON P.-ROSSETTO R.-BUCI L.-SPERONE P.-GROSSRUBATSCHER E.-REIMONDO G.- BOLLITO E.-PAPOTTI M.-SAEGER W.-HAHNER S.-KOSCHKER A.-ARVAT E.-AMBROSI B.-LOLI P.-LOMBARDI G.-MANNELLI M.-BRUZZI P.-MANTERO F.- ALLOLIO B.-DOGLIOTTI L.-BERRUTI A.
Adjuvant mitotane treatment for adrenocortical carcinoma.
N. Engl. J. Med. 356:2372/2380, 2007
PubMed Abstract

TISEO M.-MARTELLI O.-MANCUSO A.-SORMANI M.-BRUZZI P.-DI SALVIA R.-DE MARINIS F.-ARDIZZONI A.
Short hydration regimen and nephrotoxicity of intermediate to high dose cisplatin based chemotherapy for outpatient treatment in lung cancer and mesothelioma.
Tumori 93:138/144, 2007
PubMed Abstract


ALOISI A.-DI GREGORIO S.-STAGNO F.-GUGLIELMO P.-MANNINO F.-SORMANI M.-BRUZZI P.-GAMBACORTI C.-SAGLIO G.-VENUTA S.- GIUSTOLISI R.-MESSINA A.-VIGNERI P.
BCR/ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B.
Blood 107:1591/1598, 2006
PubMed Abstract

BAHL K.-KIM S.-CALCAGNO C.-GHERSI D.-PUZONE R.-CELADA F.-SELIN L.-WELSH R.
IFN induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections.
J. Immunol. 176:4284/4295, 2006
PubMed Abstract

BANDINI S.-CELADA F.-MANZONI S.-PUZONE R.-VIZZARI G.
Modelling the immune system with situated agents.
Lect. Notes Comput. Sc. 3931:231/243, 2006

BECCARO M.-COSTANTINI M.-ROSSI P.-MICCINESI G.-GRIMALDI M.-BRUZZI P.-ISDOC Study Group-SORMANI M.-MERLO F.-MORASSO G.-DI LEO S.
Actual and preferred place of death of cancer patients. Results from the italian survey of the dying of cancer (ISDOC).
J. Epidemiol. Community Health 60:412/416, 2006
PubMed Abstract

BELLINI M.-ALDUINI P.-BASSOTTI G.-BOVE A.-BOCCHINI R.-SORMANI M.-BRUZZI P.-PUCCIANI F.
Self perceived normality in defecation habits.
Dig. Liver Dis. 38:103/108, 2006
PubMed Abstract

BELLINI M.-TOSETTI C.-STASI C.-BIAGI S.-COSTA F.-BRUZZI P.-MARCHI S.
The general practitioner's management of patients with a new diagnosis of irritable bowel syndrome. Letter.
J. Clin. Gastroenterol. 40:87, 2006
PubMed Abstract

BOTTINI A.-GENERALI D.-BRIZZI M.-FOX S.-BERSIGA A.-BONARDI S.-ALLEVI G.-AGUGGINI S.-BODINI G.-MILANI M.-DIONISIO R.-BERNARDI C.-MONTRUCCOLI A.-BRUZZI P.-HARRIS A.-DOGLIOTTI L.-BERRUTI A.
Randomized phase II trial of letrozole and letrozole plus low dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients.
J. Clin. Oncol. 24:3623/3628, 2006
PubMed Abstract

CORNBERG M.-CHEN A.-WILKINSON L.-BREHM M.-KIM S.-CALCAGNO C.-GHERSI D.-PUZONE R.-CELADA F.-WELSH R.-SELIN L.
Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity.
J. Clin. Invest. 116:1443/1456, 2006
PubMed Abstract

COSTANTINI M.-MORASSO G.-MONTELLA M.-BORGIA P.-CECIONI R.-BECCARO M.-SGUAZZOTTI E.-BRUZZI P.-ISDOC Study Group-SORMANI M.-MERLO F.-DI LEO S.
Diagnosis and prognosis disclosure among cancer patients. Results from an italian mortality follow back survey.
Ann. Oncol. 17:853/859, 2006
PubMed Abstract

GENERALI D.-FOX S.-BERRUTI A.-BRIZZI M.-CAMPO L.-BONARDI S.-WIGFIELD S.-BRUZZI P.-BERSIGA A.-ALLEVI G.-MILANI M.-AGUGGINI S.- DOGLIOTTI L.-BOTTINI A.-HARRIS A.
Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer.
Endocr. Relat. Cancer 13:921/930, 2006
PubMed Abstract

GENNARI A.-AMADORI D.-DE LENA M.-NANNI O.-BRUZZI P.-LORUSSO V.-MANZIONE L.-CONTE P.
Lack of benefit of maintenance paclitaxel in first line chemotherapy in metastatic breast cancer.
J. Clin. Oncol. 24:3912/3918, 2006
PubMed Abstract

MERLO D.F.-SORMANI M.-BRUZZI P.
Molecular epidemiology: new rules for new tools?
Mutat. Res. Fund. Mol. M. 600:3/11, 2006
PubMed Abstract

TARANTINI G.-SCRUTINIO D.-BRUZZI P.-BONI L.-RIZZON P.-ILICETO S.
Metabolic treatment with L/carnitine in acute anterior ST segment elevation myocardial infarction. A randomized controlled trial.
Cardiology 106:215/223, 2006
PubMed Abstract

Per le pubblicazioni 2000-2005 del personale della struttura vedere gli elenchi generali.




|  Web Team   |   Webmaster   |   Copyright © 2002-2011 IST   |   Disclaimer   |    |